Skip to main content

Advertisement

SpringerLink
Log in

Maternal and fetal outcome after long-term bisphosphonate exposure before conception

  • Letter
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Patlas N, Golomb G, Yaffe P et al (1999) Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology 60:68–73

    Article  CAS  PubMed  Google Scholar 

  2. Mc Kenzie AF, Budd RS, Yang C et al (1994) Technicium-99m-methylene disphosphonate uptake in the fetal skeleton at 30 weeks gestation. J Nucl Med 35:1338–1341

    CAS  Google Scholar 

  3. Cremers SC, Papapoulos SE, Gelderblom H et al (2005) Skeletal retention of bisphosphonate (pamidronate) and its relation to the rate of bone resorption in patients with breast cancer and bone metastases. J Bone Miner Res 20:1543–1547

    Article  CAS  PubMed  Google Scholar 

  4. O'Sullivan SM, Grey AB, Singh R et al (2006) Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int 17:1008–1012 Epub 2006 Apr 27

    Article  PubMed  Google Scholar 

  5. Culbert EC, Schfirin BS (2006) Malignant hypercalcemia in pregnancy: effect of pamidronate on uterine contractions. Obstet Gynecol 108(3 Pt 2):789–791

    PubMed  Google Scholar 

  6. Ornoy A, Wajnberg R, Diav-Citrin O (2006) The outcome of pregnancy following pre-pregnancy or early pregnancy alendronate treatment. Reprod Toxicol 22:578–579

    Article  CAS  PubMed  Google Scholar 

  7. Munus CF, Rauch F, Ward L et al (2004) Maternal and fetal outcome after long-term pamidronate treatment before conception : a report of two cases. J Bone Miner Res 19:1742–1745

    Article  Google Scholar 

  8. Chan B, Zacharin M (2006) Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: a report of four cases. J Clin Endocrinol Metab 91:2017–2020

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Rheumatology Department, Monastir Teaching Hospital, Avenue 1er Juin, 5000, Monastir, Tunisia

    S. Hassen-Zrour, W. Korbâa, I. Béjia & N. Bergaoui

  2. Gynaecological Department, Monastir Teaching Hospital, Avenue 1er Juin, 5000, Monastir, Tunisia

    Z. Saidani

Authors
  1. S. Hassen-Zrour
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Korbâa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Béjia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Z. Saidani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. Bergaoui
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Hassen-Zrour.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hassen-Zrour, S., Korbâa, W., Béjia, I. et al. Maternal and fetal outcome after long-term bisphosphonate exposure before conception. Osteoporos Int 21, 709–710 (2010). https://doi.org/10.1007/s00198-009-0983-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-009-0983-1

Keywords

Search

Navigation